Experiences with an adaptive design for a dose-finding study in patients with osteoarthritis F Miller, M Björnsson, O Svensson, R Karlsten Contemporary clinical trials 37 (2), 189-199, 2014 | 64 | 2014 |
A two-compartment effect site model describes the bispectral index after different rates of propofol infusion MA Björnsson, Å Norberg, S Kalman, MO Karlsson, USH Simonsson Journal of pharmacokinetics and pharmacodynamics 37, 243-255, 2010 | 49 | 2010 |
Clinical pharmacokinetics of the cyclooxygenase inhibiting nitric oxide donator (CINOD) AZD3582 U Fagerholm, MA Björnsson Journal of pharmacy and pharmacology 57 (12), 1539-1554, 2005 | 36 | 2005 |
Modelling of pain intensity and informative dropout in a dental pain model after naproxcinod, naproxen and placebo administration MA Björnsson, USH Simonsson British journal of clinical pharmacology 71 (6), 899-906, 2011 | 29 | 2011 |
First human study of the investigational sedative and anesthetic drug AZD3043: a dose-escalation trial to assess the safety, pharmacokinetics, and efficacy of a 30-minute … S Kalman, P Koch, K Ahlén, SJ Kanes, S Barassin, MA Björnsson, ... Anesthesia & Analgesia 121 (4), 885-893, 2015 | 27 | 2015 |
Performance of nonlinear mixed effects models in the presence of informative dropout MA Björnsson, LE Friberg, USH Simonsson The AAPS journal 17, 245-255, 2015 | 20 | 2015 |
A bolus and bolus followed by infusion study of AZD3043, an investigational intravenous drug for sedation and anesthesia: safety and pharmacodynamics in healthy male and female … Å Norberg, P Koch, SJ Kanes, MA Björnsson, S Barassin, K Ahlén, ... Anesthesia & Analgesia 121 (4), 894-903, 2015 | 18 | 2015 |
A recirculatory model for pharmacokinetics and the effects on bispectral index after intravenous infusion of the sedative and anesthetic AZD3043 in healthy volunteers MA Björnsson, Å Norberg, S Kalman, USH Simonsson Anesthesia & Analgesia 121 (4), 904-913, 2015 | 15 | 2015 |
In vitro–in vivo correlation in man of a topically applied local anesthetic agent using numerical convolution and deconvolution K Welin-Berger, JAM Neelissen, BM Emanuelsson, MA Björnsson, ... Journal of pharmaceutical sciences 92 (2), 398-406, 2003 | 15 | 2003 |
Population pharmacokinetic analysis supports initiation treatment and bridging from sublingual buprenorphine to subcutaneous administration of a buprenorphine depot (CAM2038 … M Björnsson, C Acharya, K Strandgården, F Tiberg Clinical Pharmacokinetics 62 (10), 1427-1443, 2023 | 3 | 2023 |
Development of a population pharmacokinetic model to characterize the pharmacokinetics of intrathecally administered tominersen in cerebrospinal fluid and plasma Y Yamamoto, P Sanwald Ducray, M Björnsson, K Smart, P Grimsey, ... CPT: Pharmacometrics & Systems Pharmacology 12 (9), 1213-1226, 2023 | 3 | 2023 |
Pharmacokinetic-pharmacodynamic analysis of drug liking blockade by buprenorphine subcutaneous depot (CAM2038) in participants with opioid use disorder SL Walsh, SD Comer, JA Zdovc, C Sarr, M Björnsson, K Strandgården, ... Neuropsychopharmacology 49 (6), 1050-1057, 2024 | 1 | 2024 |